MPH Medicure Inc.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · medicure.com

2.920CAD+1.39%Mkt Cap: 22.19M $P/E: —3d ago

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$56.90BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated

$11.25BUSD

RDY

Dr. Reddy's Laboratories Limited

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc.

$6.92BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap22.19M USD

Enterprise Value21.37M USD

Revenue (TTM)23.36M USD

Gross Profit8.56M USD

Net Income (TTM)-5.17M USD

Revenue/Share3.07 CAD

Last Price2.920 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA58469E4085

Valuation

P/E (Trailing)—

P/E (Forward)-9.42

PEG0.17

EV/EBITDA-5.22

EV/Revenue0.91

P/S0.95

P/B2.63

EPS (TTM)-0.71

EPS (Forward)-0.31

52W Range

0.8500100% of range2.920

52W High2.920 CAD

52W Low0.8500 CAD

Profitability

Gross Margin40.71%

Oper. Margin-18.22%

EBITDA Margin-17.51%

Profit Margin-24.60%

ROE-54.98%

ROA-28.45%

Growth

Revenue Growth11.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-407.83K USD

CapEx (TTM)—

FCF Margin0.64%

FCF Yield0.67%

Net Debt-827.30K USD

Net Debt/EBITDA0.20

Balance Sheet

Debt/Equity0.07

Current Ratio0.97

Quick Ratio0.61

Book Value/Sh1.11 CAD

Cash/Share0.18 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:15

Split DateNov 2, 2012

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.10.44M

Float5.22M

Insiders27.30%

Institutions23.10%

Short Interest

Short Ratio0.8d

Short % Float0.05%

Short % Out.0.04%

Shares Short4.04K

Short (prev mo.)2.53K

Technical

SMA 501.961 (+48.9%)

SMA 2001.350 (+116.3%)

Beta1.27

S&P 52W Chg14.58%

Avg Vol (30d)3.51K

Avg Vol (10d)3.41K

Technical Indicators

RSI (14)79.1

MACD0.2923

MACD Signal0.3087

MACD Hist.-0.0164

BB Upper2.931 CAD

BB Middle2.648 CAD

BB Lower2.365 CAD

BB Width21.39%

ATR (14)0.1026 CAD

Vol Ratio (20d)4.09x